₹ 74.90
2.79 (3.87%)
BSE
I
Ishita Drugs & Indus
₹ 74.90
BSE
Ishita Drugs & Indus EPS Summary
The latest quarterly EPS of Ishita Drugs & Indus as of Q2 Sep 2026 stands at ₹0.54. This is a 29.87% fall quarter on quarter and 12.50% growth same quarter last year. For the FY2026 the EPS of Ishita Drugs & Indus stands at ₹2.60. This is a 10.34% fall compared with FY2025.
Ishita Drugs & Indus EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

